Exploiting the defensive sugars of HIV-1 for drug and vaccine design by Scanlan, C, Offer, J, Zitzmann, N, Dwek, R

Emerging principles for the therapeutic exploitation of glycosylation. by Dalziel, M, Crispin, M, Scanlan, C, Zitzmann, N, Dwek, R

Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens by Dunlop, D, Ulrich, A, Dwek, R, Zitzmann, N, Scanlan, C

Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions. by Baruah, K, Bowden, T, Krishna, B, Dwek, R, Crispin, M, Scanlan, C

Selective deactivation of serum IgG: A general strategy for the enhancement of monoclonal antibody receptor interactions by Baruah, K, Bowden, T, Krishna, B, Dwek, R, Crispin, M, Scanlan, C

Sugar immunogens by Dwek, R, Scanlan, C, Dunlop, D, Mansab, F, Tully, S, Wentworth, P, Zitzmann, N

Liposome treatment of viral infections by Dwek, R, Nichita-Branza, N, Petrescu, S, Pollock, S, Rudd, P, Scanlan, C, Zitzmann, N

Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12 by Fulton, Z, Doores, K, Scanlan, C, Wormald, M, Dwek, R, Wilson, I, Davis, B

Antigenic mimicry of the HIV envelope by AIDS-associated pathogens. by Dunlop, D, Ulrich, A, Appelmelk, B, Burton, D, Dwek, R, Zitzmann, N, Scanlan, C

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens by Doores, K, Bonomelli, C, Harvey, D, Vasiljevic, S, Dwek, R, Burton, D, Crispin, M, Scanlan, C

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope by Dwek R, Burton D, Smith D, Zitzmann N, Doores K, Mansab F, Dunlop DC, Scanlan C

Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope by Dunlop, D, Mansab, F, Doores, K, Zitzmann, N, Smith, D, Burton, D, Dwek, R, Scanlan, C

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. by Bonomelli, C, Doores, K, Dunlop, D, Thaney, V, Dwek, R, Burton, D, Crispin, M, Scanlan, C

A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity by Doores, K, Fulton, Z, Scanlan, C, Wormald, M, Dwek, R, Wilson, I, Burton, DR, Davis, B

Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies by Yu, X, Baruah, K, Harvey, D, Vasiljevic, S, Alonzi, D, Song, B, Higgins, M, Bowden, T, Scanlan, C, Crispin, M

An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling. by Goodfellow, J, Baruah, K, Yamamoto, K, Bonomelli, C, Krishna, B, Harvey, D, Crispin, M, Scanlan, C, Davis, B

Redirecting adenoviruses to tumour cells using therapeutic antibodies: generation of a versatile human bispecific adaptor by Vasiljevic, S, Beale, E, Bonomelli, C, Easthope, I, Pritchard, L, Seabright, G, Caputo, A, Scanlan, C, Dalziel, M, Crispin, M

Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cells by Yu, C, Crispin, M, Sonnen, A, Harvey, D, Chang, V, Evans, E, Scanlan, C, Stuart, D, Gilbert, R, Davis, S

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind... by Astronomo, R, Lee, H, Scanlan, C, Pantophlet, R, Huang, C, Wilson, I, Blixt, O, Dwek, R, Wong, C, Burton, DR

A novel form of carbohydrate recognition. The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1-2 mannose residues on the outer face of GP120 by Rudd, P, Scanlan, C, Pantophlet, R, Wormald, M, Saphire, E, Stanfield, R, Wilson, I, Katinger, H, Dwek, R, Burton, DR